Initiation of antidepressants in patients infected with SARS-COV-2: Don't forget Caution for “Paradoxical” Anxiety/Jitteriness syndrome—Commentary: Prescription of selective serotonin reuptake inhibitors in COVID-19 infection needs caution

Bonnet, Udo

doi:10.3389/fpsyt.2023.1095244

Artikel / Aufsatz Mo., 13. März. 2023 CC BY 4.0

Veröffentlicht

Initiation of antidepressants in patients infected with SARS-COV-2 : Don't forget Caution for “Paradoxical” Anxiety/Jitteriness syndrome—Commentary: Prescription of selective serotonin reuptake inhibitors in COVID-19 infection needs caution

This article is a commentary on: Prescription of selective serotonin reuptake inhibitors in COVID-19 infection needs caution by Borovcanin, M. M., Vesic, K., Balcioglu, Y. H., and Mijailović, N. R. (2022). Front. Psychiatry 13:1052710. doi: 10.3389/fpsyt.2022.1052710

Vorschau

Einordnung

Datum der Veröffentlichung:

13.03.2023

URN:

urn:nbn:de:hbz:465-20230818-084443-7

DOI:

10.3389/fpsyt.2023.1095244

Sprache:

Englisch

Ressourcentyp:

Text

Schlagwörter:

antidepressants; SNRI; SSRI; COVID-19; adverse effects; panic attacks; nausea; jitteriness

Kollektion:

E-Publikationen

Sachgruppen der Deutschen Nationalbibliographie:

610 Medizin, Gesundheit

Einrichtung:

Medizinische Fakultät, Universitätsklinikum Essen, LVR-Klinikum Essen, Klinik für Psychiatrie und Psychotherapie

Förderung:

The publication of this article was supported by the Publication Fund of the University of Duisburg-Essen.

Informationen zur Erstveröffentlichung:

Bonnet U (2023) Initiation of antidepressants in patients infected with SARS-COV-2: Don't forget Caution for “Paradoxical” Anxiety/Jitteriness syndrome—Commentary: Prescription of selective serotonin reuptake inhibitors in COVID-19 infection needs caution. Front. Psychiatry 14:1095244. doi: 10.3389/fpsyt.2023.1095244

Published: 13 March 2023

Versionskennzeichen: